If you can see this message, your browser does not support canvas and needs an update. Sorry. :(
Tuesday, April 20, 2021 
Market Status: Closed
About us and Governance Investor Relations Contact
Advanced search

Market News


FARMACEUTICA REMEDIA SA - RMAH

H1 2018 report

Release Date: 8/9/2018 8:00:10 AM

IRIS Code: D16A8

 

COMMUNICATION FOR THE SEMESTER I 2018

of the Board of Directors of
Farmaceutica REMEDIA S.A.

 

  1. Important events to report

During the period 01.01.2018 – 30.06.2018 there were no important events that have a particular impact on the financial position of the company Farmaceutica REMEDIA S.A.

  1. The general description of the financial position and of the issuer’s performances and of its branches afferent to the 1st semester of 2018

 During the period 01.01.2018 – 30.06.2018, the commercial company Farmaceutica REMEDIA S.A. recorded the following consolidated financial results:

 

Crt.Nr.

Indicator

Realisations during January-June 2017 (Lei)

Realisations during January – June 2018 (Lei)

Evolution 2018/2017

 (%)

1.

Net sales of goods *

156.747.074

209.781.696

+ 33,83

2.

Other operating revenues

2.110.806

2.520.858

+ 19,43

3.

Total operating income

158.857.880

212.302.554

+ 33,64

4.

Total operational costs *

157.267.890

209.599.209

+ 33,28

5.

Operating result

1.589.990

2.703.345

+ 70,02

6.

Financial result

75.220

-3.079

- 104,09

7.

Gross result

1.665.210

2.700.266

+ 62,16

 

  * Including trade discounts granted/received

 

A breakdown of sales of goods by segment of activity is presented as follows:

 

Lei

REMEDIA Pharmacies

46.823.805

22,24%

Distribution

112.734.657

53,55%

Hospitals & Private Clinics Distribution

39.084.787

18,57%

Other operations

11.880.349

5,64%

Total

210.523.598

100,00 %

 Other operating revenues” mainly comprise the following categories of revenues:  collected rents,  marketing services, sale of assets, logistic services, other services.

    

3. The financial statements as at 30.06.2018 were not audited by the independent financial auditor.

 

4. Economic-financial indicators as at 30.06.2018

 

 

 

 

LIQUIDITY AND WORKING CAPITAL

Farmaceutica REMEDIA S.A.

Farmaceutica REMEDIA Distribution & Logistics SRL

 

Afferent liquidity (Current assets/ current debts)

1,10

1,01

 

Current assets

34.127.668

199.873.243

 

Current debts

30.959.169

197.463.308

 

Indebtedness degree (loaned capital/equity x 100)

0%

72,74%

 

Average customer balance*

0

2.835.988

 

Net turnover

40.091.979

3.898.996

 

Turnover speed for client debit items (Average customer balance /turnover*180x)

46 days

111 days

 

Average customer balance

12.244.829

119.155.920

 

Net turnover

47.840.975

194.071.986

 

Turnover speed of stocks (average stock/ net COGS)*180

66 days

47 days

 

Average stock

13.471.628

46.906.747

 

Net COGS

36.669.293

179.455.713

 

             

 *including financial leasing

 Notes:

1) Current liquidity – the level of the indicator reflects a good payment capacity, therefore a low risk for creditors, certifying that the companies are able to cover short-term debts based on receivables and cash availability.

2) Indebtedness degree expresses the effectiveness of credit risk management, indicating potential funding, liquidity problems, with influences in meeting the commitments. In the case of Farmaceutica REMEDIA S.A. there is no risk while for Farmaceutica REMEDIA Distribution & Logistics SRL the value of the indicator indicates an average risk. In calculating this indicator, the borrowed capital comprises both bank loans and finance lease liabilities.

3) Turnover speed for client debit items expresses the effectiveness of the company in collecting its claims, i.e. the number of days until the debtors pay their debts to the company. Considering the dynamics of sales and the specificity of receivables collections in the distribution of drugs, we believe that the indicator’s value is a normal one for both companies, in the given circumstances. The dynamics of this indicator was for Farmaceutica REMEDIA S.A.  pharmacies the following: 30 days for the first semester of 2017, 29 days in the second quarter of II 2017 and 47 days in the 2nd quarter of 2018. In the case of Farmaceutica REMEDIA Distribution & Logistics SRL, we have :117 days for the 1st semester 2017, 126 days in the 2nd quarter of 2017 and 110 days in the 2nd quarter of 2018.

4) The days on hand indicator value (66 respectively, 47 days) can be considered to fall within the activity specificity, exceeding the limit imposed by the internal procedures of the company (45 days) in the case of Farmaceutica REMEDIA S.A. In the case of Farmaceutica REMEDIA S.A. the indicator had the following evolution: 64 days in the first semester of 2017, 68 days in the 2nd quarter of 2017 and 69 days in the 2nd quarter of 2018. At Farmaceutica REMEDIA Distribution & Logistics SRL we have: 34 days for the 1st semester of 2017, 32 days for the 2nd quarter of 2017 and 50 days for the 2nd quarter of 2018.

 

Dear investors,

 The full semester version of the Half-Year Report 2018 will be available on the issuer's own website and on the link from the IRIS platform.

 

President of the Board of Administrators –

TARUS” – Valentin Norbert Tarus e.U.

 

 

                                                                                                                                                                                       

 



 Print

Information provided by IRIS, the news platform of the Bucharest Stock Exchange.

______________________

Bucharest Stock Exchange ("BVB") is not responsible for the content of this News item. Issuers whose financial instruments are traded on markets operated by BVB are required to report in accordance with current legal and regulatory provisions. BVB publishes these Reports as market administrator, appointed by ASF. When, for investors’ information, Reports are published, either signed by different persons, or with conflicting information, legal liability lies fully with the signatories. BVB disclaims any obligation or responsibility towards issuers or third parties, regarding the reality, completeness and accuracy of information provided by them and distributed by BVB. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries. Terms and conditions, including restrictions on use and distribution apply.


©2016 Bucharest Stock Exchange. All rights reserved